Differences

This shows you the differences between two versions of the page.

--- glp-1analogs [2026/08/18 23:36] – [Adverse effects and C/I] gary1
+++ glp-1analogs [2026/09/08 03:12] (current) – [Actions] gary1
@@ Line 27: / Line 27: @@
       * appears to show a 10% reduced cumulative risk of dementia compared to metformin in type II diabetics and a 12% lower risk of developing Alzheimer's disease, and a 25% lower risk of developing non-vascular dementias (([[https://www.news-medical.net/news/20250722/GLP-1-receptor-agonists-linked-to-lower-dementia-risk-in-type-2-diabetes.aspx]]))
     * anti-inflammatory
-      *  appear to reduce biomarkers such as C-reactive protein (CRP) and tumor necrosis factor-alpha (TNF-α)
+      * appears to reduce biomarkers such as C-reactive protein (CRP) and tumor necrosis factor-alpha (TNF-α)
+      * appears to reduce asthma attacks by 40% and COPD exacerbations by 20%(([[https://www.news-medical.net/news/20260907/GLP-1-treatment-linked-to-4025-fewer-asthma-attacks.aspx]]))
     * metabolic properties